Coffee County couple accused of drug trafficking, police say
ENTERPRISE, Ala. (WDHN) — An Enterprise couple is behind bars and faces charges of drug trafficking, possession, and chemical endangerment of a child.
The Coffee County Sheriff's Office says they executed a search warrant at a home in the 2000 block of County Road 723 on February 4.
The raid allegedly uncovered an array of drugs and resulted in the arrest of Brandon Paul Frederick, 37, and his wife Stephanie Marie Frederick, 40.
The two are charged with nine counts of possession of a controlled substance, one count of drug trafficking, and one count of chemical endangerment of a child.
CCSO says they recovered ketamine, marijuana, mushrooms, Xanax, kratom, THC extract, edibles, vapes, and U.S. Currency.
Both were taken to the Coffee County jail and are being held with a bond pending.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
2 killed after gunman opens fire on car on West Side overnight
CHICAGO — A shooting on the city's West Side overnight left two men dead, police say. According to Chicago police, the deadly shooting unfolded just before midnight in the 100 block of North Laramie Avenue in Austin. Read more: Latest Chicago news and headlines Officers say the victims, a 38-year-old man and another man believed to be between 30 and 50 years of age, were sitting in a car in the area when an unknown individual approached and opened fire on them. Both men suffered gunshot wounds to the head and were taken to the hospital, where they were later pronounced dead. Currently, it is unclear what led to the shooting, and no arrests have been made. Authorities have not yet identified the victims, and an investigation into the deadly shooting is currently underway. LATEST CASES: Missing people in Chicagoland Officers ask anyone with information on the shooting to contact CPD Area Four Detectives at 312-746-8251 or dial 911. Those with information that could help authorities in their investigation can also leave a tip at Tips can be filed anonymously. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Business Upturn
3 hours ago
- Business Upturn
IOVA SHAREHOLDERS: Iovance Biotherapeutics, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 14 Deadline (NASDAQ:IOVA)
NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting Investors have until July 14, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Iovance securities. The case is pending in the U.S. District Court for the Northern District of California and is captioned Sundaram v. Iovance Biotherapeutics, Inc., et al. , No. 25-cv-04177. Why was Iovance Sued for Securities Fraud? Iovance is a commercial-stage biopharmaceutical company focused on the development of treatments for melanoma and other solid tumor cancers. The Company commercially launched its key melanoma treatment Amtagvi in February 2024. Iovance administers Amtagvi at the Company's authorized treatment centers ('ATCs'). As alleged, Iovance repeatedly touted its ATCs as a driver of demand for Amtagvi. In truth, Iovance's ATCs were experiencing long timelines to begin treating patients with Amtagvi, and ineffective patient identification and patient selection for treatment was causing high patient drop-offs at the ATCs. The Stock Declines as the Truth is Revealed On May 8, 2025, Iovance reported disappointing financial results for 1Q25 and announced it was 'revising full-year 2025 revenue guidance.' The Company blamed 'recent launch dynamics,' including slow 'treatment timelines for new ATCs' and 'the variable pace at which ATCs began treating patients,' which 'differs from center to center.' Iovance also blamed the poor results on high 'patient drop-off' due to inadequate 'patient selection' for treatment. On this news, the price of Iovance stock declined more than 44%, from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025. Click here if you suffered losses: What Can You Do? If you invested in Iovance you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
Yahoo
4 hours ago
- Yahoo
Goose Creek PD to hold 7th annual Hot Pursuit 5K
GOOSE CREEK, S.C. (WCBD) – The Goose Creek Police Department will hold its 7th annual Hot Pursuit 5K this weekend. Money raised through the event will support some of the department's community-driven initiatives, like 'Operation Christmas Joy' and 'Shop with a Badge'. The race on Saturday will start near the municipal complex and traverse paved hiker/biker trails and roadways before returning to the complex. Roads along the race route will be closed to ensure the safety of participants and spectators. 'Our officers will permit vehicle traffic to pass when there is a lull in the runners; however, all drivers will have to drive away from the race route,' the department said. Saturday's race begins at 8 a.m. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
